InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Beraud Jill, 董事. Officer active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 33 filings have been published. Activity tracked since 5 May 2021. The latest transaction was disclosed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Beraud Jill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报33 总计
54 股0Class A Common StockSEC:0001999371-26-017422:0
8,381 股0Class A Common StockSEC:0001999371-26-009019:0
75 股0Class A Common StockSEC:0001999371-26-004640:0
85 股0Class A Common StockSEC:0001999371-25-017124:0
82 股0Class A Common StockSEC:0001999371-25-011151:0
88 股0Class A Common StockSEC:0001999371-25-005903:0
108,679 股0Class A Common StockSEC:0001999371-25-004779:0
56 股0Class A Common StockSEC:0001839882-25-013573:0
28,606 股@ US$3.65100.0% 占其流量Common StockSEC:0000950170-25-015341:0
60 股0Class A Common StockSEC:0001839882-24-039788:0
52 股0Class A Common StockSEC:0001999371-24-010538:0
42 股0Class A Common StockSEC:0001999371-24-006713:0
15,000 股0Common StockSEC:0001479290-24-000084:0
7,642 股0Class A Common StockSEC:0001999371-24-005255:0
69 股0Class A Common StockSEC:0001999371-24-002763:0
87 股0Class A Common StockSEC:0001999371-23-000150:0
88 股0Class A Common StockSEC:0001209191-23-046788:0
129 股0Class A Common StockSEC:0001209191-23-031617:0
3,534 股0Common StockSEC:0001479290-23-000058:0
77,410 股0Common StockSEC:0001209191-23-025241:0
10,251 股0Class A Common StockSEC:0001209191-23-025261:0
87 股0Class A Common StockSEC:0001209191-23-013528:0
190 股0Class A Common StockSEC:0001209191-22-058617:0
152 股0Class A Common StockSEC:0001209191-22-046620:0
222 股0Class A Common StockSEC:0001209191-22-031970:0
33 条申报中的 25 条
About Beraud Jill
Beraud Jill is Administrateur at Levi Strauss & Co and Revance Therapeutics, Inc. She has 32 filings in total, and across the 32 sampled filings, the period runs from 2021-05-07 to 2026-04-24. The modal transaction nature is Attribution, and the buy and sell amounts are both EUR 0 in the sampled filings.
